Cancer in the first 18 months of life
Open Access
- 24 November 2020
- journal article
- Published by Elsevier BV in Anales de Pediatría (English Edition)
- Vol. 93 (6), 358-366
- https://doi.org/10.1016/j.anpede.2020.02.006
Abstract
No abstract availableKeywords
Funding Information
- Asociación Pablo Ugarte
- a 2016 research grant of the Fundación Mutua Madrileña
- Asociación Esperanza y Sonrisas
This publication has 13 references indexed in Scilit:
- The RB1 Story: Characterization and Cloning of the First Tumor Suppressor GeneGenes, 2019
- Comprehensive evaluation of context dependence of the prognostic impact of MYCN amplification in neuroblastoma: A report from the International Neuroblastoma Risk Group (INRG) projectPediatric Blood & Cancer, 2019
- Metastatic neuroblastoma in infants: are survival rates excellent only within the stringent framework of clinical trials?Clinical and Translational Oncology, 2016
- Cancer in children and adolescents in Spain: incidence, treatment setting and provider specialtyClinical and Translational Oncology, 2015
- Neuroblastoma after Childhood: Prognostic Relevance of Segmental Chromosome Aberrations, ATRX Protein Status, and Immune Cell InfiltrationNeoplasia, 2014
- Treatment of infant leukemias: challenge and promiseHematology, 2013
- Segmental chromosomal alterations lead to a higher risk of relapse in infants with MYCN-non-amplified localised unresectable/disseminated neuroblastoma (a SIOPEN collaborative study)British Journal of Cancer, 2011
- Excellent Outcome With Reduced Treatment in Infants With Nonmetastatic and Unresectable Neuroblastoma Without MYCN Amplification: Results of the Prospective INES 99.1Journal of Clinical Oncology, 2011
- Epigenetic alterations in disseminated neuroblastoma tumour cells: influence of TMS1 gene hypermethylation in relapse risk in NB patientsZeitschrift für Krebsforschung und Klinische Onkologie, 2010
- Tumores renales en niños menores de un añoAnales de Pediatría, 2006